Clinical Trials
14 trialsNCT06512662 2026-04-06
PAKO-HDJ
Clinique Pasteur Lanroze
Phase NA Recruiting
NCT04124198 2025-12-31
QoLATI
Rigshospitalet, Denmark
Phase NA Active not recruiting
NCT06604494 2025-09-22
RADEFILAC
University Hospital, Clermont-Ferrand
Phase NA Recruiting
NCT05388773 2025-06-19
Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
University of Pittsburgh
Phase 2 Recruiting
NCT06627075 2025-02-13
SUGAR
Center Eugene Marquis
Phase NA Recruiting
NCT03769467 2024-11-14
Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)
Atara Biotherapeutics
Phase 1/2 Terminated
NCT05830240 2023-04-26
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer
Shanghai Yunying Medical Technology
Phase EARLY_PHASE1 Unknown
NCT05258383 2023-04-18
ELISA
Assistance Publique - Hôpitaux de Paris
Unknown
NCT05246891 2022-03-07
Rehabilitation Nursing Program in Otolaryngology
University of Évora
Completed
NCT00588640 2016-08-10
Study of D-Methadone in Patients With Chronic Pain
Memorial Sloan Kettering Cancer Center
Phase 1/2 Completed
NCT00413075 2015-07-08
Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma
Valerio Therapeutics
Phase 1 Completed
NCT00413322 2015-07-08
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
Valerio Therapeutics
Phase 1 Completed
NCT00050388 2008-06-24
Phase II Trial of Allovectin-7® for Head and Neck Cancer
Vical
Phase 3 Completed
NCT00001167 2008-03-04
Ultrasound Evaluation of Tongue Movements in Speech and Swallowing
National Institutes of Health Clinical Center (CC)
Completed